Trends in Antifungal Drug Susceptibility of Cryptococcus neoformans Isolates in the United States: 1992 to 1994 and 1996 to 1998

Practice Guidelines for the Management of Cryptococcal Disease

2000 • 1,099 citations

Antimicrobial-Drug Resistance

1996 • 1,087 citations

Cryptococcal Meningitis in Patients with AIDS

1988 • 400 citations

Cryptococcal Meningitis and AIDS

1993 • 280 citations

Cryptococcosis: Population‐Based Multistate Active Surveillance and Risk Factors in Human Immunodeficiency Virus–Infected Persons

1999 • 276 citations

Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts

1993 • 197 citations

Correlation of Fluconazole MICs with Clinical Outcome in Cryptococcal Infection

2000 • 172 citations

Susceptibility testing of Cryptococcus neoformans: a microdilution technique

1992 • 151 citations

Identification of Patients with Acute AIDS-Associated Cryptococcal Meningitis Who Can Be Effectively Treated with Fluconazole: The Role of Antifungal Susceptibility Testing

1996 • 140 citations

Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease Active Surveillance Group

1996 • 113 citations

Detection of Resistance to Amphotericin B among Cryptococcus neoformans Clinical Isolates: Performances of Three Different Media Assessed by Using E-Test and National Committee for Clinical Laboratory Standards M27-A Methodologies

1998 • 109 citations

Evaluation of etest for determining in vitro susceptibility of yeast isolates to amphotericin B

1998 • 91 citations

Comparison of multilocus enzyme electrophoresis and random amplified polymorphic DNA analysis for molecular subtyping of Cryptococcus neoformans. The Cryplococcal Disease Active Surveillance Group

1995 • 79 citations

Molecular Subtypes and Antifungal Susceptibilities of Serial Cryptococcus neoformans Isolates in Human Immunodeficiency Virus-Associated Cryptococcosis

1996 • 75 citations

Correlation of In Vitro Azole Susceptibility with In Vivo Response in a Murine Model of Cryptococcal Meningitis

1993 • 71 citations

Azole Drug Resistance as a Cause of Clinical Relapse in AIDS Patients with Cryptococcal Meningitis

1995 • 52 citations

Multicenter evaluation of broth microdilution method for susceptibility testing of Cryptococcus neoformans against fluconazole

1996 • 46 citations

Influence of Shaking on Antifungal Susceptibility Testing of Cryptococcus neoformans : a Comparison of the NCCLS Standard M27A Medium, Buffered Yeast Nitrogen Base, and RPMI–2% Glucose

2000 • 41 citations

In-vitro susceptibility of Cryptococcus neoformans isolates to fluconazole and itraconazole

1998 • 38 citations

Resistance to Systemic Antifungal Agents

1984 • 31 citations

Decreased Fluconazole Susceptibility of a Relapse Cryptococcus neoformans Isolate After Fluconazole Treatment

1995 • 19 citations

Comparison of D0870 and fluconazole in the treatment of murine cryptococcal meningitis

1995 • 9 citations

Two-site comparison of broth microdilution and semisolid agar dilution methods for susceptibility testing of Cryptococcus neoformans in three media

1993 • 9 citations